Search NTRBW
NutriBand Inc.
Nasdaq, Nasdaq · CIK 1676047
Last close0.55
Daily changen/a
10 Years gain-62.07%
Dividends TTM0
Dividend yieldn/a
Fundamental Analysis
NTRBW · STANDARD
SIC 3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Fiscal year end 0131
Fundamental
27.9Momentum
0.0Acceleration
0.0Confidence
83.0Annual Revenue8
Quarterly Revenue25
Annual CFO10
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality4.7 / 25
Capital Efficiency3.2 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators5.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Warnings
Operating margin compression · MEDIUMOperating margin compressed by 27.5014 percentage points.
Heavy share dilution · HIGHDiluted share count increased 9.2594%.
ROIC declining · MEDIUMROIC declined by 96.8757 percentage points.
Key Metrics
Revenue Growth TTM-23.31%OK
Revenue CAGR 3Y-0.69%OK
Gross Margin32.84%OK
Operating Margin-436.47%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-313.49%OK
Incremental Operating Margin 3Y-85,771.15%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y9.26%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Jan 31, 2026 | $2.04M | $566,308.00 | -$8.32M | -$5.13M | -$5.14M | 27.81% | -408.41% | -252.37% | -311.3% | 11.64M |
| 2026 FY Jan 31, 2025 | $2.14M | $743,317.00 | -$10.28M | -$4.63M | -$4.72M | 34.74% | -480.7% | -220.54% | -161.49% | 10.61M |
| 2025 FY Jan 31, 2024 | $2.09M | $862,105.00 | -$4.87M | -$3.53M | -$3.58M | 41.34% | -233.63% | -171.64% | -52.97% | 7.95M |
| 2024 FY Jan 31, 2023 | $2.08M | $750,409.00 | -$4.48M | -$2.99M | -$3.07M | 36.08% | -215.19% | -147.46% | -52.16% | 8.46M |
| 2023 FY Jan 31, 2022 | $1.42M | $554,310.00 | -$6.11M | -$2.81M | -$2.89M | 38.98% | -429.68% | -203.27% | -69.32% | 7.93M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.84M | sum latest 4 fiscal quarters Revenue | OK | 0001213900-26-097701, 0001213900-25-120204 |
| Revenue Growth TTM | -23.31% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001213900-26-097701, 0001213900-25-120204 |
| Revenue CAGR 3Y | -0.69% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001213900-26-049399 |
| Revenue CAGR 5Y | 16.63% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001213900-26-049399 |
| Gross Profit CAGR 3Y | -8.96% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001213900-26-049399 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001213900-26-097701, 0001213900-25-120204 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 32.84% | Gross Profit / Revenue | OK | 0001213900-26-097701, 0001213900-25-120204 |
| Operating Margin | -436.47% | Operating Income / Revenue | OK | 0001213900-26-097701, 0001213900-25-120204 |
| ROIC | -313.49% | NOPAT / Average Invested Capital | OK | 0001213900-26-097701, 0001213900-25-120204 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001213900-26-097701 |
| Current Ratio | 4.21x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $0.15 | Revenue / Diluted Shares | OK | 0001213900-26-097701, 0001213900-25-120204 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |